Teleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) Shares outstanding
Teleflex Incorporated's shares outstanding at the end of fiscal 2025 was $44.7M, down 5.03% from $47.1M in fiscal 2024. At the end of the quarter to 30 June 2026 it was $43.7M. Over the past ten years it has ranged from $44.7M (fiscal 2025) to $48.1M (fiscal 2015) — the current reading is the lowest in ten years. Teleflex Incorporated ranks 32nd of 47 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $44.7M | (5.03%) |
| FY2024 | $47.1M | (0.44%) |
| FY2023 | $47.3M | (0.01%) |
| FY2022 | $47.3M | (0.25%) |
| FY2021 | $47.4M | 0.30% |
| FY2020 | $47.3M | 0.42% |
| FY2019 | $47.1M | 0.62% |
| FY2018 | $46.8M | 0.29% |
| FY2017 | $46.7M | (2.06%) |
| FY2016 | $47.6M | (0.86%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $43.7M | (1.35%) |
| Mar 2026 | $44.3M | (1.04%) |
| Dec 2025 | $44.7M | 1.10% |
| Sep 2025 | $44.2M | (0.21%) |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| AVTR Avantor, Inc. compare | $680.9M |
| BLCO Bausch + Lomb Corporation compare | $361.5M |
| MMED MiniMed Group, Inc. compare | $281.0M |
| NVST Envista Holdings Corporation compare | $163.4M |
| PLSE Pulse Biosciences, Inc compare | $71.9M |
| ATR AptarGroup, Inc. compare | $64.1M |
| MMSI Merit Medical Systems, Inc. compare | $60.4M |
| TFX Teleflex Incorporated | $43.7M |
| ICUI ICU Medical, Inc. compare | $25.1M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on TFX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement